Ossur Hf : Share options granted
Announcement from Össur hf. No.17/2012
Reykjavik, 3 May 2012
Össur - Share options granted
Today, Össur hf. has granted 2,050,000 share options to middle management. The
exercise price now is DKK 8.71, i.e. the Company's average share price on NASDAQ
OMX Copenhagen 20 trading days prior to the grant date. The share options were
granted in accordance with the Company's share option scheme implemented on 24
April 2012. Further details on the share option scheme, including the key terms
and conditions, can be found in the Company's announcement No. 16/2012 published
on 24 April 2012.
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at the
following web-site: http://www.ossur.com/investormailings
About Össur
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that
help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports, prosthetic limbs and compression
therapy, including the Flex-Foot Cheetah carbon fiber running prostheses used
by "The Blade Runner," renowned double-amputee sprinter Oscar Pistorius. A
recognized "Technology Pioneer", Össur invests significantly in research and
product development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are further
empowered via Össur's educational programs and business solutions.
Headquartered in Iceland, Össur has major operations in the Americas, Europe and
Asia, with additional distributors worldwide. www.ossur.com
Forward-Looking Statements
This press release includes "forward-looking statements" which involve risks and
uncertainties that could cause actual results to differ materially from results
expressed or implied by these statements. Össur hf. undertakes no obligation and
does not intend to update these forward-looking statements to reflect events or
circumstances occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this press release. All forward-looking statements are qualified in
their entirety by this cautionary statement.